Public Plans
Public plans are plans created using the DMP Tool service and shared publicly by their owners. They are not vetted for quality, completeness, or adherence to funder guidelines.
Plans (80)
NIH-Default DMSP
Transcriptional Dysregulation in the Pathogenesis of NAFLD
Baran Ersoy, Weill Cornell Medicine
NIH-Default DMSP
Racial Equity Tools to Prevent Youth Violence and to Reduce Racially Inequitable Youth Outcomes (Racial Equity Project, REP) in Worcester, MA.
Laurie Ross, Clark University (clarku.edu)
NIH-Default DMSP
Signature for Pain Recovery IN Teens (SPRINT)
Emma Biggs, Stanford University (stanford.edu)
NIH-GEN: Generic (Current until 2023)
Blocking the long noncoding RNA, INCR1, with an antisense oligonucleotide (ASO) to reverse GBM immuno-evasion”
E.antonio Chiocca, PSC Partners Seeking a Cure (pscpartners.org)
NIH-GEN DMSP (Forthcoming 2023)
Rhode Island IDeA Network of Biomedical Research Excellence
Christopher Hemme, University of Rhode Island (ww2.uri.edu)
NIH-GEN DMSP (Forthcoming 2023)
PERSIST study
Emily Ricotta, National Institutes of Health (nih.gov)
NIH-GDS: Genomic Data Sharing
Improving the quality of stem-cell derived insulin-producing cells
Xing Jian, Washington University in St. Louis (wustl.edu)
NIH-GDS: Genomic Data Sharing
Data Management with the Broad Institute's Data Use Oversight System (DUOS)
Pamela Bretscher, Broad Institute (broadinstitute.org)
NIH-GEN: Generic (Current until 2023)
Mechanisms and Targeted Control of Pancreatic ß-Cell Antioxidant Response
Alissa Novak, Indiana University (iu.edu)
